Treatment involving patient's family cuts mental health hospital admissions, study finds
The approach focuses on the patient priorities, seeing the same clinicians, and involving people close to them.
World's first patient to undergo live AI-assisted brain surgery has tumour removed
Without brain surgery guided by live AI assistance, Rhys Hibbert could have lost his sight to a tumour.
Plug-in solar panels are coming to a shop near you - here's what to know
The UK government claimes panels could help homes "significantly cut" energy bills.
Super Bowl champions Seahawks to be sold in record $9.6bn deal
NFL owners approve the $9.612bn record sale of the reigning Super Bowl champions Seattle Seahawks to a group led by bi…
Meta's $18bn settlement may hasten reckoning for social media on child safety
Perhaps our days of doomscrolling are numbered, writes the BBC's technology editor Zoe Kleinman.
How Dolly Parton's business savvy helped her succeed far beyond the charts
While country music and films brought her fame, her entrepreneurial zeal brought her fortune.
The question dominating Indian politics: Is it worse when women swear?
Rahul Gandhi's comments renew the debate over gender disparity in reactions to insults hurled at PM Narendra Modi.
'Mini-Rodri' Gonzalez shown he will be loved at Newcastle
Nico Gonzalez is given a rapturous welcome before Newcastle's Carabao Cup win against West Brom following the £52m mid…
Slovan Bratislava through in Champions League after extra-time brilliance
A brilliant flick over the keeper from Cristian Martinez in extra time is enough to get Slovan Bratislava past Celje a…
How to follow Thursday's Champions League draw - and who is in each pot?
BBC Sport's Ask Me Anything team explains when the league phase draw for the 2026-27 Champions League is, as well as l…
Unexpected chat between OpenAI agents led to Hugging Face hack
OpenAI's cyber agents banded together to perform a hack during a security test.
US drug agency approves breakthrough treatment for pancreatic cancer
Experts have hailed the drug, daraxonrasib, as a game changer for one of the world's deadliest cancers.